ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Note
Revised

Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute

[version 2; peer review: 2 approved]
PUBLISHED 11 Jun 2019
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Research on Research, Policy & Culture gateway.

Abstract

International experts have recommended actions that funders can take to improve the value of research investments. They state that self-assessment and public sharing are the basis for accountability and improvement. We examined our policies and practice to determine the extent to which the Patient-Centered Outcomes Research Institute’s (PCORI) policies and practices as a research funder align with international best practice recommendations. A self-audit of current policies and practice against 17 recommendations and 35 sub-recommendations representing five major stages of research production, based on adapted methods used for self-assessment by another funder, was performed.  Fit of existing PCORI policies and practices with 35 sub-recommendations, qualitative assessment of adequacy (area of strength; area of partial strength; area of growth; not applicable) for 17 recommendations for five stages of research production was assessed. Of the 17 recommendations, 15 were applicable to PCORI’s research mission and focus.  PCORI has policies and practices in place for all elements of six recommendations (“area of strength”) and policies that address each element but with some still in active development for three (“area of partial strength”). PCORI is partially addressing six of the 15 relevant recommendations (“area of growth”). Areas for growth include making study protocols publicly available, improving policies on data sharing, and enhancing collaboration with other funders to reduce redundant funding. A voluntary consortium of international funders is underway to encourage further progress, including additional self-assessment and public sharing for accountability. These findings indicate PCORI has undertaken efforts to align its funding practices with international recommendations to ensure the value of public dollars invested in research.  Further efforts will likely require additional coordination and collaboration between funders and stakeholders.

Keywords

Biomedical Research/standards, Research Design/standards, Biomedical Research/economics, Biomedical Research/methods

Revised Amendments from Version 1

We have revised the article and expanded the methods section in response to comments from reviewers (Hans Lund and Mona Nasser).

See the authors' detailed response to the review by Hans Lund
See the authors' detailed response to the review by Mona Nasser

Introduction

In 2014, in response to concerns about avoidable waste in research prioritization, conduct, and reporting1, The Lancet published a series of articles which identified specific recommendations for the biomedical research community to ensure value and minimize inefficiency in research26. Research funders were a major target for these recommendations, along with regulators, journals, academic institutions and researchers themselves. Prompted by these and related activities, the biomedical research community around the world has begun considering best practices to ensure value in publicly-funded research. As key contributors7, research funders are encouraged to audit and update their own policies and practice, even as external assessments of funders are also undertaken8,9.

In light of these trends, the Patient-Centered Outcomes Research Institute (PCORI), undertook an organizational case study of its policies and practices. PCORI was created in 2010 to address research needs of a range of healthcare stakeholders through clinical comparative effectiveness research, and ranks among the top 10 US non-commercial funders of health research (see Healthresearchfunders.org). Our goals were to examine and report how closely PCORI adheres to best practice recommendations for research funders (i.e., to foster transparency), to highlight areas of needed development for PCORI (to foster public accountability), and to consider how other research funders in the US and elsewhere can examine, report, and adopt best practices for supporting value in research (to foster enterprise-wide efficiency).

Methods

To maximize comparability, we adapted another funder’s self-assessment methods (M. Westmore, personal communication, June 15, 2016; See Adding Value in Research from the National Institute for Health Research). PCORI staff (KD, LF, EW) examined PCORI’s existing policies and initiatives against 17 recommendations for funding agencies from the Lancet series26; after initial assessment, we consulted with additional PCORI staff members to confirm accurate interpretation of policies and processes (see PCORI site). Many of the 17 Lancet recommendations include multiple components. To accurately assess and transparently communicate our performance across all intended components of these recommendations, we subdivided some recommendations to capture each dimension within them separately, for a total of 35 sub-recommendations. (Table 1). Four authors (KD, LF, EW, GN) independently categorized fidelity to the 17 recommendations as: 1) “area of strength” –PCORI’s practices reasonably address all sub-recommendations; 2) “area of partial strength” –PCORI’s practices reasonably or partially address all sub-recommendations; 3) “area of growth” –PCORI’s practices do not address all sub-recommendations, either reasonably or partially; or 4) not applicable. We resolved discrepancies through discussion and final ratings reflect consensus.

Results

Table 1 represents a detailed summary (through November 2018) of PCORI’s policies and practices related to ensuring value in research. Across the 17 recommendations (35 sub-recommendations), two recommendations were not applicable (1, 8), and one recommendation primarily applies to non-funders (both 9a, 9b). For the 15 relevant recommendations, PCORI at least partially addresses most of the relevant sub-recommendations (28/33). Our consensus process categorized PCORI’s existing policies and practices as “areas of strength” for 6/15 applicable recommendations, “partial strength” for 3/15. PCORI’s authorizing legislation, although preceding the Lancet recommendations by several years, mandated a number of these (indicated in bold in the table).

Table 1. Assessment of PCORI’s policies and practices related to ensuring value in research.

LANCET SERIES RECOMMENDATIONSRELATED PROCESSES OR INITIATIVES AT PATIENT-CENTERED
OUTCOMES RESEARCH INSTITUTE (PCORI)
SELF-ASSESSMENT
QUESTIONS ARE RELEVANT TO USERS OF RESEARCH
1.  More investigations into research should be done to identify factors associated with
successful replication of basic research and translation to application in health care,
and how to achieve the most productive ratio of basic to applied research
  •   Not applicable - PCORI is authorized to fund comparative
clinical effectiveness research with direct application to
health care decision making.
Not applicable
2.  Research funders should make information available about how decisions are
made about what research to support (2a) and fund investigations into the effects of
initiatives to engage potential users of research in research prioritization (2b)
  •   PCORI’s multi-stakeholder Board of Governors meetings are
conducted in an open forum, allowing members of the public
to listen and provide comment on the proceedings. (2a)
  •   PCORI incorporates potential users of research throughout
the decision-making process from identification of research
priorities to topic refinement, in review of applications for
research funding. PCORI publishes criteria and processes
guiding the topic pathway which determines focused research
funding opportunities. (2a)
  •   PCORI’s Engagement Awards provide funding for patient and
stakeholder groups for prioritization of research topics. (2b)
  •   PCORI has funded studies focused on improving the methods
for research prioritization. (2b)
Area of strength
3.  Research funders and regulators should demand that proposals for additional
primary research are justified by systematic reviews (3a), showing what is already
known (3b), and increase funding for the syntheses of existing evidence (3c)
  •   PCORI’s Methodology Standards require that any proposed
study be justified by evidence gaps identified through gap
analysis or systematic review. (3a)
  •   The first of the PCORI application Merit Review Criteria requires
that applications demonstrate the potential for the study to fill
critical gaps in evidence. (3a; 3b)
  •   PCORI’s legislation specifies its use of evidence synthesis
to increase quality and relevance of information; programs
for funding evidence syntheses have been expanding since
2016 including systematic reviews and updates, individual
patient data meta-analysis and other evidence synthesis
approaches. (3c)
  •   PCORI has funded studies on improving methods for systematic
reviews. (3c)
Area of partial strength
4.  Research funders and research regulators should strengthen and develop sources
of information about in progress research (4a), ensure that this information is used
by researchers (4b), insist on publication of protocols at study inception (4c), and
encourage collaboration to reduce waste (4d)
  •   Abstracts and project statuses for all research awards are
available on PCORI’s website with links to project registration in
clinicaltrials.gov, PROSPERO, and Registry of Patient Registries
(RoPR). (4a)
  •   PCORI launched several topic-based, multi-stakeholder
networks to increase cross-learning, information sharing,
collaboration, and uptake of findings. (4d)
  •   PCORI consults with other US funders when considering new
research topics and initiatives to prevent duplication and
identify areas for collaboration or co-funding. (4d)
Area of growth
APPROPRIATE RESEARCH DESIGN, CONDUCT, AND ANALYSIS ARE EMPLOYED
5.  Make publicly available the full protocols (5a), analysis plans or sequence of
analytical choices (5b), and raw data (5c) for all designed and undertaken
biomedical research
  •   PCORI’s authorizing legislation requires that research
protocols, methods of research and analysis, and other
information be made publicly available concurrent with the
release of research findings. (5a; 5b)
  •   PCORI’s policy on Replication and Reproducibility of Research
and Data Sharing requires awardees to submit the final protocol
to PCORI, requires applicants/awardees to submit a data-
sharing plan, and permits PCORI to request data sharing and to
share protocols upon request. (5a; 5b; 5c)
Area of growth
6.  Maximize the effect to bias ratio in research through: defensible design and conduct
standards (6a), a well-trained methodological research workforce (6b), continuing
professional development (6c), and involvement of non-conflicted stakeholders (6d)
  •   PCORI established a set of Methodology Standards for
relevant research designs and requires that all PCORI-
funded research adhere to relevant PCORI Methodology
Standards. (6a)
  •   PCORI offers training opportunities to develop the research
workforce and support researchers in understanding and
applying the Methodology Standards, including continuing
medical education (CME). (6b; 6c)
  •   PCORI’s requires that any conflicts of interest be disclosed
for advisory panel members, individuals involved in the
peer-review process, Board and Methodology Committee,
and for executive staff of the Institute. PCORI’s Policy on
Conflict of Interest (COI), Confidentiality, and Non-Disclosure
ensures that application merit reviewers provide objective
evaluations of applications for funding. (6d)
  •   Individual patient data meta-analyses are set up to involve third
party researchers with strict COI consideration consistent with
guidance from the Institute of Medicine and the World Health
Organization. (6d)
Area of strength
7.  Reward (with funding and academic or other recognition) reproducibility practices
and reproducible research and enable an efficient culture for replication of research
Not yet developedArea of growth
RESEARCH REGULATION AND MANAGEMENT IS EFFICIENT
8.  People regulating research should use their influence to reduce other causes of
waste and inefficiency in research
  •   Not applicable –PCORI does not regulate research.Not applicable
9.  Regulators and policy makers should work with researchers, patients, and health
professionals to streamline and harmonize the laws, regulations, guidelines, and
processes that govern whether and how research can be done (9a), and ensure that
these factors are proportionate to the plausible risks associated with the research
(9b)
  •   PCORI follows practices recommended by Office for Human
Research Protections, National Institutes of Health, and seeks
counsel to harmonize human subject protections. (9a; 9b)
  •   Accelerating Patient-Centered Outcomes Research and
Methodological Research is one of PCORI’s five national
priorities for research. PCORI’s Methods Program is funding
research on novel approaches to improving research efficiency
in informed consent (9a; 9b)
  •   PCORnet, the national patient-centered clinical research
network launched by PCORI, has done extensive work related
to multi-institutional contracting, IRB oversight, data sharing and
data linkage. (9a, 9b)
Area of partial strength
10.  Researchers and research managers should increase the efficiency of recruitment
and retention of participants, data monitoring, and data sharing in research through
the use of research designs known to reduce inefficiencies (10a), and do additional
research to learn how efficiency can be increased (10b)
  •   PCORI’s multi-stakeholder Advisory Panel on Clinical
Trials advises PCORI on the selection, research design,
implementation, and technical issues of clinical trials
for patient-centered outcomes research. Recruitment
subcommittee advises on strategies for appropriate patient
recruitment, accrual and retention of participants in clinical
trials. (10a)
  •   PCORI launched the National Patient-Centered Clinical
Research Network (PCORnet), a collaboration involving 33
individual partner networks, intended to conduct clinical
research incorporating patient health information more
efficiently and at lower cost than is currently possible; intended
efficiencies in recruitment, retention, data monitoring and data
sharing still being explored. (10b)
  •   PCORI is funding research on novel approaches to improving
research efficiency in recruitment, appropriate use of
observational data for valid causal inference, and methods to
allow for real-world clinical research. (10b)
Area of partial strength
11.  Everyone, particularly individuals responsible for health-care systems, can help to
improve the efficiency of clinical research by promoting integration of research in
everyday clinical practice
  •   PCORI promotes integration of research in everyday clinical
practice through:
          •   Demonstration: 139 healthcare sites are embedded within
PCORnet sites
          •   Funding: PCORI conducts many pragmatic studies in real-
world settings
          •   Training: PCORI and the Agency for Healthcare Research
and Quality are co-funding workforce training within
learning health systems.
          •   Dissemination: PCORI works with stakeholders, including
healthcare systems, to promote dissemination and
implementation of key research findings and provides
competitive funding opportunities for these purposes.
Area of strength
ALL RESEARCH IS REPORTED AND DATA ARE ACCESSIBLE
12.  Institutions and funders should adopt performance metrics that recognize full
dissemination of research (12a) and reuse of original datasets by external
researchers (12b)
  •   PCORI-funded research findings are required to convey
full results including considerations specific to certain
subpopulations and study limitations. (12a)
  •   PCORI’s Board of Governors monitors high-level performance
metrics on dissemination of research findings. (12a)
  •   PCORI has developed initial Data Management and Data
Sharing policies but not performance measures. (12b)
Area of growth
13.  Investigators, funders, sponsors, regulators, research ethics committees, and
journals should systematically develop and adopt standards for the content of study
protocols (13a) and full study reports (13b), and for data sharing practices (13c)
  •   Awardees submit final research reports using a standard
template designed to increase the quality and transparency
of reporting. Awardees are required to consider the PCORI
Methodology Standards for data integrity, rigorous analyses,
and reporting and to follow international checklists for reporting
and assessing quality (e.g. CONSORT, STROBE, PRISMA).
(13b)
  •   PCORI’s Policy on Data Management and Data Sharing was
approved by the PCORI Board of Governors on September
7, 2018. The Policy was informed, in part, by a pilot project
that brought together PCORI awardees with data repository
organizations. (13c)
Area of growth
14.  Funders, sponsors, regulators, research ethics committees, journals, and
legislators should endorse and enforce study registration policies (14a), wide
availability of full study information (14b), and sharing of participant-level data for
all health research (14c)
  •   PCORI requires awardees to register awards in clinicaltrials.gov,
PROSPERO, and Registry of Patient Registries (RoPR) (14a)
  •   PCORI’s Public Access to Journal Articles policy provides
funds for all projects to cover open access fees and requires all
publications to be deposited in PubMed Central (PMC) (14b)
Area of growth
RESEARCH REPORTS ARE COMPLETE, UNBIASED, AND USABLE
15.  Funders and research institutions must shift research regulations and rewards to
align with better and more complete reporting
  •   PCORI findings are required to undergo a Peer Review
process assessing scientific quality and level of adherence
to PCORI methodology standards prior to publication.
  •   Receipt of funds dependent on completion of contract
milestones, including registration of study on clinicaltrials.gov
and completion of final peer-reviewed report to be posted on
PCORI website.
Area of strength
16.  Research funders should take responsibility for reporting infrastructure that
supports good reporting and archiving
  •   Lay and Clinician Abstracts that are comprehensible, useful,
fully convey findings, discuss considerations specific to
subpopulations, and address limitations as well as research
needs are required by law to be available on PCORI website
within 90 days of study completion.
  •   The PCORI website provides infrastructure for transparent
reporting. Audio files, Spanish translations, and other translation
products aid PCORI in the dissemination of research findings.
Area of strength
17.  Funders, institutions, and publishers should improve for authors and reviewers the
capability and capacity for high-quality and complete reporting
  •   PCORI’s Peer Review process assesses scientific quality and
level of adherence to PCORI methodology standards prior to
publication of research findings. Reviewers provide feedback to
study investigators to ensure complete reporting.
Area of strength

Recommendations sourced from Lancet series on ensuring value and minimizing waste in research26

Bolded text indicates process or policy mandated by PCORI’s authorizing legislation

Discussion

Our consensus process categorized PCORI’s existing policies and practices as meeting criteria for “areas of strength” or “partial strength” for many of the recommendations, and we also identified clear areas for growth. Examples of strengths include PCORI’s requirements that funded research adhere to methodology standards to minimize bias and that all study results are posted on the PCORI website to enhance public access to findings. On the other hand, PCORI has not yet fully developed its policies and practices related to rewarding research replication and reproducibility (Recommendation 7). Further development of performance metrics, standardized approaches to all study-related reporting, and enforcement of key policies (Recommendations 12, 13, 14) offer other areas ripe for growth, particularly if undertaken in coordination with others across the research enterprise. PCORI like many funders, is still actively developing its practices related to publicly sharing information, including raw data, as early as possible from funded research (Recommendations 4, 5). For example, making research protocols publicly available (Recommendation 5a) is required by PCORI’s authorizing legislation, but timing and format were not specified, and our current practices may not be ideal. PCORI now requires funded investigators to submit a study protocol and record its details in an appropriate registry but does not yet specify a standard protocol format nor require protocol publication before study completion. To our knowledge, just one funder (NIHR) clearly publishes study protocols at the time of award10. Nonetheless, making study protocols available at study inception can benefit the public by providing a detailed record of the planned study, which may help avoid unwitting duplication of research underway and support detection of important study deviations and post-hoc changes.

There is also opportunity for improvement through further development of policies and practices related to research data sharing and re-use. While funders can require awardees to share data from funded research and trial participants are supportive of such sharing11, many researchers remain concerned about the impact on their work12. PCORI’s policy on data sharing13 was informed by a public comment process as well as pilot work assessing time and effort required for investigators to prepare their data for sharing and on identifying appropriate repository models. Accelerating the practice of responsible data sharing necessitates broad coordination between journals, academic institutions, and data-repository organizations, alongside consistent requirements and support from funders. PCORI plans to monitor progress in these areas and conduct an updated self-assessment in two years.

Efforts to reduce waste and increase value in research are in alignment with trials transparency14, research integrity15, administrative efficiency16, and other similar initiatives. PCORI and other health research funders are in consortium to encourage further development and voluntary adherence to international best practice recommendations for research funders, (17; see Ensuring Value in Research (EVIR) website). The Ensuring Value in Research Funders’ Forum is exploring other initiatives, such as evaluating and sharing best practices for similar challenges that funders face, and considering what avenues exist to enhance efficiency and value in the full research agenda across funders. Beyond the consortium, greater transparency and coherence between funders and key players producing health research---including journals, research institutions, sponsors, and regulators---remains vital for tangible progress in our shared efforts7,18.

Limitations: Our methods are limited by self-assessment, but findings are consistent with audit results for PCORI from external assessors10. In addition, the availability of policies or current practices represent only the first step, with actual performance measurement needed. Finally, while the Lancet series highlights areas for improvement for funders and others across the research enterprise, the impact of implementing and adhering to these recommendations on research value has yet to be demonstrated.

Data availability

Underlying data

All data underlying the results are available as part of the article and no additional source data are required.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 14 Mar 2019
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Whitlock EP, Selby JV, Dunham KM et al. Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute [version 2; peer review: 2 approved]. F1000Research 2019, 8:288 (https://doi.org/10.12688/f1000research.18471.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 11 Jun 2019
Revised
Views
11
Cite
Reviewer Report 11 Jun 2019
Mona Nasser, Peninsula Dental School, Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, UK 
Approved
VIEWS 11
No ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Nasser M. Reviewer Report For: Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute [version 2; peer review: 2 approved]. F1000Research 2019, 8:288 (https://doi.org/10.5256/f1000research.21339.r49744)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 14 Mar 2019
Views
20
Cite
Reviewer Report 14 May 2019
Mona Nasser, Peninsula Dental School, Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, UK 
Approved
VIEWS 20
This is a very important project and the authors have put a lot of effort to ensure a structured approach to self-evaluation of the organisation.
 
It would be helpful to have more details on the methods: ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Nasser M. Reviewer Report For: Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute [version 2; peer review: 2 approved]. F1000Research 2019, 8:288 (https://doi.org/10.5256/f1000research.20209.r45788)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 28 May 2019
    Kelly Dunham, Patient-Centered Outcomes Research Institute, Washington, 20036, USA
    28 May 2019
    Author Response
    We greatly appreciate the reviewer's questions and suggestions. We made several revisions to the article in response to the comments.

    At least two PCORI staff members reviewed each recommendation. ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 28 May 2019
    Kelly Dunham, Patient-Centered Outcomes Research Institute, Washington, 20036, USA
    28 May 2019
    Author Response
    We greatly appreciate the reviewer's questions and suggestions. We made several revisions to the article in response to the comments.

    At least two PCORI staff members reviewed each recommendation. ... Continue reading
Views
20
Cite
Reviewer Report 25 Apr 2019
Hans Lund, Centre for Evidence-Based Practice, Western Norway University of Applied Sciences (HVL), Bergen, Norway 
Approved
VIEWS 20
The study is a report of a self-audit done by one of the top 10 non-commercial funders in USA. The aim was to evaluate to what degree the funding agency follow international recommendations to improve the value of research investments.
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Lund H. Reviewer Report For: Examining the role of funders in ensuring value and reducing waste in research: An organizational case-study of the Patient-Centered Outcomes Research Institute [version 2; peer review: 2 approved]. F1000Research 2019, 8:288 (https://doi.org/10.5256/f1000research.20209.r47387)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 11 Jun 2019
    Kelly Dunham, Patient-Centered Outcomes Research Institute, Washington, 20036, USA
    11 Jun 2019
    Author Response
    We greatly appreciate the reviewer's comments and suggestions. 

    While we routinely monitor PCORI practice, we plan to conduct a second self-assessment in two years. We added this information to the discussion ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 11 Jun 2019
    Kelly Dunham, Patient-Centered Outcomes Research Institute, Washington, 20036, USA
    11 Jun 2019
    Author Response
    We greatly appreciate the reviewer's comments and suggestions. 

    While we routinely monitor PCORI practice, we plan to conduct a second self-assessment in two years. We added this information to the discussion ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 14 Mar 2019
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.